Mifepristone and misoprostol for abortion

References

Citations

1. American College of Obstetricians and Gynecologists (2005, reaffirmed 2007). Medical management of abortion. ACOG Practice Bulletin No. 67. Obstetrics and Gynecology, 106(4): 871–882.

2. U.S. Food and Drug Administration (2006). FDA Public Health Advisory: Sepsis and Medical Abortion Update. Available online: http://www.fda.gov/cder/drug/advisory/mifeprex200603.htm.

3. Holmquist S, Gilliam M (2008). Induced abortion. In RS Gibbs et al., eds., Danforth's Obstetrics and Gynecology, 10th ed., pp. 586–603. Philadelphia: Lippincott Williams and Wilkins.

4. Middleton T, et al. (2005). Randomized trial of mifepristone and buccal or vaginal misoprostol for abortion through 56 days of last menstrual period. Contraception, 72(5): 328–332.

5. Guttmacher Institute (2008). In Brief: Facts on Induced Abortion in the United States. Available online: http://www.guttmacher.org/pubs/fb_induced_abortion.html.

Author:	Healthwise Medical Writer	Last Updated: September 29, 2008
Medical Review:	Joy Melnikow, MD, MPH - Family Medicine Rebecca H. Allen, MD, MPH - Obstetrics and Gynecology
© 1995-2009 Healthwise, Incorporated. Healthwise, Healthwise for every health decision, and the Healthwise logo are trademarks of Healthwise, Incorporated.This information does not replace the advice of a doctor. Healthwise disclaims any warranty or liability for your use of this information. Your use of this information means that you agree to the Terms of Use. How this information was developed to help you make better health decisions.